No Data
No Data
How Peter Marks' FDA Departure Is Impacting Pharma, Biotech Stocks
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics
Express News | Taysha Gene Therapies Down 10.9%, Solid Biosciences Down 7.2%, US-Listed Shares of CRISPR Therapeutics Down 3.8%, Beam Therapeutics Down 3.2% Premarket
Trump's Medical Tariffs Could Significantly Hurt These European Healthcare Firms
CRISPR Therapeutics Insider Ups Holding During Year
CRISPR Therapeutics COO to Step Down
sooogod : nbis.
GOGOY : Tem will be the next